Enterprise Financial Services Corp (EFSC)’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,311
| Closed | -$220K | – | 171 |
|
|
2025
Q4 | $220K | Sell |
2,311
-116
| -5% | -$11.4K | 0.11% | 146 |
|
|
2025
Q3 | $237K | Sell |
2,427
-7
| -0.3% | -$725 | 0.12% | 129 |
|
|
2025
Q2 | $261K | Buy |
2,434
+165
| +7% | +$16.7K | 0.14% | 131 |
|
|
2025
Q1 | $229K | Buy |
2,269
+27
| +1% | +$2.72K | 0.14% | 131 |
|
|
2024
Q4 | $200K | Buy |
+2,242
| New | +$197K | 0.11% | 147 |
|
|
2021
Q3 | – | Sell |
-2,797
| Closed | -$120K | – | 508 |
|
|
2021
Q2 | $120K | Hold |
2,797
| – | – | 0.02% | 264 |
|
|
2021
Q1 | $108K | Sell |
2,797
-39
| -1% | -$1.48K | 0.02% | 281 |
|
|
2020
Q4 | $102K | Sell |
2,836
-4,667
| -62% | -$168K | 0.02% | 282 |
|
|
2020
Q3 | $287K | Sell |
7,503
-50
| -0.7% | -$1.93K | 0.06% | 165 |
|
|
2020
Q2 | $265K | Buy |
7,553
+4
| +0.1% | +$144 | 0.06% | 172 |
|
|
2020
Q1 | $246K | Sell |
7,549
-212
| -3% | -$8.28K | 0.06% | 167 |
|
|
2019
Q4 | $351K | Hold |
7,761
| – | – | 0.08% | 156 |
|
|
2019
Q3 | $316K | Sell |
7,761
-130
| -2% | -$5.51K | 0.07% | 163 |
|
|
2019
Q2 | $339K | Sell |
7,891
-279
| -3% | -$10.7K | 0.07% | 165 |
|
|
2019
Q1 | $314K | Sell |
8,170
-390
| -5% | -$14.9K | 0.07% | 175 |
|
|
2018
Q4 | $303K | Buy |
8,560
+100
| +1% | +$3.63K | 0.19% | 97 |
|
|
2018
Q3 | $326K | Sell |
8,460
-535
| -6% | -$18.7K | 0.17% | 101 |
|
|
2018
Q2 | $294K | Sell |
8,995
-217
| -2% | -$6.54K | 0.15% | 115 |
|
|
2018
Q1 | $252K | Buy |
9,212
+86
| +0.9% | +$2.34K | 0.13% | 125 |
|
|
2017
Q4 | $226K | Sell |
9,126
-4,251
| -32% | -$117K | 0.11% | 132 |
|
|
2017
Q3 | $390K | Sell |
13,377
-100
| -0.7% | -$2.76K | 0.19% | 98 |
|
|
2017
Q2 | $374K | Buy |
13,477
+31
| +0.2% | +$823 | 0.19% | 95 |
|
|
2017
Q1 | $334K | Sell |
13,446
-400
| -3% | -$9.73K | 0.16% | 102 |
|
|
2016
Q4 | $299K | Sell |
13,846
-183
| -1% | -$3.99K | 0.15% | 106 |
|
|
2016
Q3 | $334K | Sell |
14,029
-170
| -1% | -$4.05K | 0.19% | 93 |
|
|
2016
Q2 | $332K | Sell |
14,199
-101
| -0.7% | -$2.19K | 0.2% | 91 |
|
|
2016
Q1 | $269K | Sell |
14,300
-10,950
| -43% | -$192K | 0.16% | 100 |
|
|
2015
Q4 | $466K | Buy |
+25,250
| New | +$452K | 0.28% | 81 |
|
|
2015
Q2 | – | Sell |
-175
| Closed | -$4K | – | 1090 |
|
|
2015
Q1 | $4K | Hold |
175
| – | – | ﹤0.01% | 850 |
|
|
2014
Q4 | $2K | Sell |
175
-77
| -31% | -$984 | ﹤0.01% | 1002 |
|
|
2014
Q3 | $3K | Sell |
252
-116
| -32% | -$1.46K | ﹤0.01% | 892 |
|
|
2014
Q2 | $5K | Hold |
368
| – | – | ﹤0.01% | 790 |
|
|
2014
Q1 | $5K | Buy |
368
+77
| +26% | +$1.01K | ﹤0.01% | 797 |
|
|
2013
Q4 | $3K | Sell |
291
-200
| -41% | -$2.36K | ﹤0.01% | 887 |
|
|
2013
Q3 | $6K | Buy |
491
+86
| +21% | +$930 | ﹤0.01% | 692 |
|
|
2013
Q2 | $4K | Buy |
+405
| New | +$3.44K | ﹤0.01% | 664 |
|
Other funds holding BSX
VCM
VPM
Enterprise Financial Services Corp (EFSC)'s BSX Position: Q1 2026 in Review
Enterprise Financial Services Corp (EFSC) sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,311 shares — an estimated $220K sold.
Enterprise Financial Services Corp (EFSC) first reported a position in BSX in Q2 2013 and held it in 36 quarters. The position peaked at $466K in Q4 2015. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Enterprise Financial Services Corp (EFSC) reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
- Enterprise Financial Services Corp (EFSC) sold 2,311 Boston Scientific shares in Q1 2026, an estimated $220K.
- Enterprise Financial Services Corp (EFSC) first reported a position in Boston Scientific in Q2 2013 and held it in 36 quarters.
- Enterprise Financial Services Corp (EFSC)'s Boston Scientific position peaked at $466K in Q4 2015.
- 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2026, filed 5 May 2026.